Pancreatic Cancer Research

ResearcherShiga University of Medical ScienceNo recent work listed

Hirokazu Inoue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9800-9449; OpenAlex author ID A5101956177. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells. Last author DOI 10.3892/ijo.2022.5398↗
  2. Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer. Last author DOI 10.1002/mc.23045↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tokio Terado · 2 shared papers, 2019–2022 · strength 0.23
  2. Yukihiro Tambe · 2 shared papers, 2019–2022 · strength 0.23
  3. Hiroshi Kido · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.